» Articles » PMID: 33128399

Impact of Adjunctive Procedures on Recombinant Human Fibroblast Growth Factor-2-mediated Periodontal Regeneration Therapy: A Retrospective Study

Overview
Journal J Periodontol
Date 2020 Oct 31
PMID 33128399
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Human fibroblast growth factor-2 (rhFGF-2) therapy has been used for periodontal tissue regeneration. However, few studies have reported their adjunctive procedures based on strategy of tissue engineering. The aim of this retrospective study is to assess the adjunctive effects of modified papilla preservation technique (mPPT) and combination with autogenous bone grafts (AG) on the rhFGF-2 therapy.

Methods: Total of 44 sites underwent rhFGF-2 therapies and the evaluations in the survey periods. The primary outcome was set to the radiographic bone fill by radiographic examinations at 6 and 12 months after surgeries. We analyzed the correlation between influencing factors and the primary outcome, and differences of therapeutic effect by combination therapy with mPPT and that with AG.

Results: After surgeries, probing depth (PD), clinical attachment level (CAL) and bone defects significantly improved. The improvements of radiographic bone fill were significantly positive correlated with a number of bone walls, combination with mPPT, and AG at 6 months after surgeries, and with combination with mPPT and AG at 12 months after surgeries. The significant differences of improvements of radiographic bone fill were demonstrated between combination with or without mPPT at 12 months after surgeries, and with or without AG at 6 and 12 months after surgeries. Moreover, the multiple linear regression analysis for the radiographic bone fill indicated the significant regression coefficient with conducts of mPPT.

Conclusions: mPPT and AG had powerfully adjunctive effects on rhFGF-2 therapy. Further studies are needed in order to verify by randomized clinical trials.

Citing Articles

Combined Effects of Fibroblast Growth Factor-2 and Carbonate Apatite Granules on Periodontal Healing: An In Vivo and In Vitro Study.

Miyata N, Mori S, Murakami T, Bizenjima T, Seshima F, Imamura K Biomedicines. 2024; 12(8).

PMID: 39200129 PMC: 11352071. DOI: 10.3390/biomedicines12081664.


Early wound healing at 1 week postoperatively in periodontal tissue regeneration therapy: enamel matrix derivative versus recombinant human fibroblast growth factor.

Nakayama Y, Ogihara-Takeda M, Saito Y, Yamaguchi A, Ogata Y J Periodontal Implant Sci. 2024; 54(6):405-418.

PMID: 39058346 PMC: 11729240. DOI: 10.5051/jpis.2400740037.


Recombinant human fibroblast growth factor and autogenous bone for periodontal regeneration: Alone or in combination? A randomized clinical trial.

Kojima K, Kamata Y, Shimizu T, Sato S, Suzuki S, Takanashi Y J Periodontal Res. 2024; 59(6):1162-1174.

PMID: 38853125 PMC: 11626695. DOI: 10.1111/jre.13310.


Comparison of early wound healing using modified papilla preservation technique between enamel matrix derivative and recombinant human fibroblast growth factor.

Nakayama Y, Tabe S, Igarashi K, Moriya S, Katsumata T, Kobayashi R J Periodontal Implant Sci. 2023; 54(4):236-252.

PMID: 38014774 PMC: 11377897. DOI: 10.5051/jpis.2303080154.


Multi-Omics Data Integration Reveals Key Variables Contributing to Subgingival Microbiome Dysbiosis-Induced Inflammatory Response in a Hyperglycemic Microenvironment.

Lafleur S, Bodein A, Mbuya Malaika Mutombo J, Mathieu A, Joly Beauparlant C, Minne X Int J Mol Sci. 2023; 24(10).

PMID: 37240180 PMC: 10218861. DOI: 10.3390/ijms24108832.